Sara Ricardo

18PUBLICATIONS
59CO-AUTHORS
Haematological tumoursMolecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Proteomics and intermolecular interactions (excl. medical proteomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Aug 27, 2026
Anti-PD-1 Treatment Restores Effector Function in Exhausted-like T Cells from Malignant Ascites of Ovarian Cancer Patients.

|May 04, 2026
Re-Thinking Pharmacokinetics in Ovarian Cancer: What Do Organoids Add?

|Dec 30, 2025
Galanthamine Fails to Reverse P-gp-Mediated Paclitaxel Resistance in Ovarian Cancer Cell Lines.

Nélia Fonseca, Mariana Nunes, Patrícia M A Silva

|May 04, 2025
P-cadherin overexpression is associated with early transformation of the Fallopian tube epithelium and aggressiveness of tubo-ovarian high-grade serous carcinoma.

Rita Canário, Ana Sofia Ribeiro, Inês Morgado

|Jan 25, 2025
Ivermectin Strengthens Paclitaxel Effectiveness in High-Grade Serous Carcinoma in 3D Cell Cultures.

Mariana Nunes, Sara Ricardo

|Nov 27, 2024
Metformin Impairs Linsitinib Anti-Tumor Effect on Ovarian Cancer Cell Lines.

Diana Luísa Almeida-Nunes, João P N Silva, Mariana Nunes

Pageof 3

Frequent Collaborators

10 joint publications

Mariana Nunes

5 joint publications

Leonor David

3 joint publications

Ricardo Jorge Dinis-Oliveira

3 joint publications

Diana Luísa Almeida-Nunes